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Children frequently present with a history of repeated infections. When these infections are
serious and respond poorly to normally successful treatment programs, suspicion of a basic
defect in one or more host defense mechanisms may be raised. In such cases defects in
humoral or cell-mediated immunity, phagocytic cell functions or the complement system
must be sought. Much of our knowledge about the development and functions of these
cooperating but independent systems allows clinical observations to provide a generally ac-
curate prediction of the nature of the defect involved. The degree of sophistication with which
the systems can be evaluated and the possibilities for therapeutic manipulation are rapidly in-
creasing. In this article are outlined the basic pathophysiological mechanisms needed to ap-
proach these increasingly recognized problems.
Repeated, severe and frequently fatal infections provide the major problem for
the 4000 (estimated) children in the United States with severely compromised host-
defense mechanisms. Partial, less severe, defects are being increasingly recognized,
making it all the more important for the pediatrician whose suspicion is aroused to
understand the nature and pathophysiology of such defects and the way to
investigate them.
Children in the first 5 yr oflife are certainly less well equipped to handle infections
than older children. According to the Bills of Mortality for the city of London for
the year 1750, 50% of children were dying before their fifth birthday. Most of these
children died from infection. Apart from the lack of useful therapeutic procedures
and the total lack of an appreciation for hygiene a further two factors compromised
infection fighting. Malnutrition certainly compromises the efficiency of the immune
system (1) and was no doubt a major problem in that period. However, a second
problem, still with us today, is the slow and, therefore, inadequate nature of the
primary immune response itself. If one were to be allowed to redesign the human
immune system, the major improvement one could suggest would be in this area.
Today, as then, children are born with three weapon systems almost ready to do
battle with the microorganisms to which they are rapidly introduced. Thesedefenses
consist of a specific immune system mediated by lymphocytes, a reticuloendothelial
system mediated by the body's phagocytic cells, and a complement system com-
posed of 11 serum proteins. Interaction between the three systems is essential for
health.
With good good nutrition and hygienic conditions, infections, though common in
young children, are infrequently serious problems. Nevertheless, the defense
mechanisms are not perfect in the normal child, and it is easy to understand how a
further reduction in host defense efficiency secondary to abnormalities within such
systems can result in life-threatening infection.
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The fundamental problem when talking about children who have too frequent
infections is in deciding who they are. When are frequent infections too frequent to
be explained away by environmental considerations thus arousing a suspicion of
inadequate defense mechanisms? In general, when an experienced pediatrician says a
child is having too many infections to fit into the normal spectrum of such occur-
rences an inefficient host response to infection should be suspected. Many, indeed
most, of these recurrent infections will be due to local factors (e.g., inadequate
drainage from sinuses, cystic fibrosis, etc.) These must be considered before the
rarer, more basic defects covered in this discussion. In the absence ofsuch local fac-
tors, especially in patients with the "clues" listed below, basic defects should be
considered.
Many children have six to eight respiratory infections per year (2), and this may
be increased if there is exposure to older siblings and other children. In the immu-
nologically normal child such infections are mild, with little fever, last a few days,
and characteristically the child recovers completely between infections. One's suspi-
cion should be raised if a child suffers an even greater number of infections of
unusual severity. Frequently infections in immune-deficient children are of
prolonged duration, are associated with unexpected complications and are
associated with organisms one usually considers to have a low degree of patho-
genicity. Commonly bacteriostatic antibiotics usually effective in the management
of a particular bacterial infection prove ineffective as host mechanisms cannot com-
plete the destruction of the organism. In such circumstances the following defects
should be considered, and appropriate evaluations initiated.
The primary immune deficiencies can be divided into five categories listed here in
order of frequency (3). (1) isolated humoral immune deficiency (50-75%);
(2) combined cellular and humoralimmunedeficiency (25%); (3) isolated deficiency
of cell-mediated immunity (5%); (4) phagocytic cell anomalies (1%); (5) com-
plement deficiencies (1%).
Any of the above can result in a patient presenting with frequent infections. The
clinical history, however, may suggest a specific defect. A child with an intact
defense mechanism may suffer one attack of bacterial pneumonia, meningitis,
sepsis, or osteomyelitis; two such episodes would strongly suggest a possible
humoral defect as bacteria are dealt with by this system and abnormality here is the
most common immune deficiency. However, complement and phagocytic cell de-
fects can present similarly.
A child who has had a smallpox vaccination with a normal response almost cer-
tainly has no major defect in cell-mediated immunity. A child who has experienced
the exanthem of a viral illness, e.g., measles, likewise has demonstrated a normal
cell-mediated reaction as these rashes are manifestations ofT-cell responses to the
virus (4). Conversely, a stormy time with measles or chickenpox, recurrent moni-
liasis, or a severe vaccinial reaction suggests problems within theCMI system.
There follows a briefdescription ofthe major relevant facts required for an appre-
ciation ofthe primary immunedeficiencies.
The immune system is composed of two independent but frequently cooperating
mechanisms. One results in the production of antibody by plasma cells and is con-
trolled by lymphocytes derived from the bone marrow and thus referred to as "B"
lymphocytes (5). The other provides cell-mediated -immunity (CMI) and utilizes
physical contact between lymphocyte and antigen for destruction of the latter. The
lymphocytes for this system are educated in the thymus and are called "T"
lymphocytes (5). It is only within these lymphocyte-mediated systems that
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specificity and memory are found. They are the generals of the host defense
mechanism, while the soldiers consist of phagocytic cells and complement
components.
During fetal life lymphocytes are programmed with surface-bound antigen-
recognition units that allow each lymphocyte to recognize one antigen, or more cor-
rectly one section ordeterminant ofan antigen (6). As we areprogrammed to recog-
nize many thousands of different antigens, it follows that there can be very few
lymphocytes capable of recognizing one antigen. Hence, the first encounter with an
antigen (microorganism in our context) results in a slow and relatively inefficient
response. This response does include division of those lymphocytes involved in the
reaction with a subsequent expansion in the number ofcells (memory cells) that can
recognize that organism (7). The immune response ofsuch lymphocytes is more so-
phisticated and efficient than the response oftheirparental cells.
In the normally germ-free intra-uterine environment B and T cells do not en-
counter antigens and thus we are born without apopulation ofmemory lymphocytes
and cannot make an optimal response to first postnatal encounters with pathogens.
To partially protect the newborn infant, a considerable amount of maternal IgG
crosses the placenta and provides the infant with antibodies against those antigens
the mother's immune system has dealt with (8). As this antibody has ahalf-lifeof26
days, it can protect the child for only 4 to 6 mo during which time he will make his
own primary response to many organisms (9).
Functionally, antibodies provide our primary defense against bacteria while the
cell-mediated immune system protects us from viral, fungal, intracellular bacterial
and protozoal infections (10).
Humoral Immune Deficiencies
In man, B lymphocytes from the bone marrow begin to populate lymph nodes by
12 wk of gestation. They have on their surface an immunoglobulin receptor for an-
tigen that, on encountering said antigen, will trigger a humoral immune response
(11). The B lymphocyte will undergo a number of divisions forming memory B
lymphocytes and plasma cells which are factories manufacturing the antibody that
was on the surface of the B lymphocyte from which it was derived (11). Plasma cells
secrete 2000 molecules per second of this antibody. The early B lymphocytes have
receptors for antigens composed of IgM on their surface but later, B lymphocytes
develop with IgG and then IgA on their surface (12). As the plasma cell product is
related to these surface receptors, the primary immune response is mainly IgM in
character while later responses produce mainly IgG antibodies. Cells with IgG on
their surface are the progeny ofcells with IgM on their surface, while cells with IgA
on their surface are the progeny of IgG-bearing cells (13). Thus, the M- G-'A
progression is reflected clinically as defects at each step have been described, the
most common being the arrest ofthe production line at IgG resulting in isolated IgA
deficiency (14).
The IgA system has a special role to play in protecting our mucosal and intestinal
surfaces, and at birth the concentration of IgA in saliva is higher than in the serum
suggesting adevelopment ofthe secretory IgA system independent ofthe serum IgA
system (15). In addition, the lymphoid-associated epithelial cells of much of the in-
testinal mucosa manufacture a special molecule called secretory component which
can attach to the secretory IgA and greatly aid in itsdelivery to the mucosal surface
(16).
Antibodies are efficient at eliminating bacteria, as once combined with the
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organism they can (depending on class) activate the complement system and
phagocytic cells producing a powerful inflammatory response in which the bacteria
are killed and eliminated (17).
Defects of humoral immunity range from a congenital sex-linked agammaglobu-
linemia through an isolated IgA deficiency to a temporary state ofprolonged hypo-
gammaglobulinemia of infancy. Quantitative immunoglobulin determinations (not
immunoelectrophoresis) and the examination of saliva or tears for IgA provide an
excellent screening test for such deficiencies. The discovery of a severe defect calls
for the enlistment of a clinical immunologist to further classify thedefect and advise
on treatment. A negative Schick test provides evidence of the development of anti-
bodies against diphtheria while iso-hemagglutinins indicate at least a capacity for
IgM production. An immunological laboratory can assay peripheral blood for B
lymphocytes. Normally they make up 35% of the lymphocytes in human peripheral
blood (18). They are absent in congenital agammaglobulinemia. The laboratory can
also stimulate B lymphocytes in tissue culture and look for antibodies against
human antibodies found in the serum of some patients with a selective immuno-
globulin abnormality (19).
Treatment of these conditions involves a number of nonspecific measures com-
mon to all immune deficiency problems as well as the administration of gamma
globulin. Such children require extraordinary amounts of pediatric care but the re-
sults are well worth the effort. These children should have their own bedroom when
possible and within reason should be kept away from sources of infections. Their
teeth should be kept in good repair. If they have any antibody-forming capacity,
killed vaccines should be administered. As chest infections are their most common
problem, they require the same attention to drainage, etc. that is required for the
child with cystic fibrosis. Commercial gamma globulin should be given to such
children except those with isolated IgA deficiency. For them it cannot help as com-
mercial preparations contain only tiny amounts of IgA; however, it can be harmful
as the small amount of IgA that is present will be antigenic for these children and
anaphylactic responses may develop (20). The correct amount ofgammaglobulin to
give is the amount that keeps the child free of systemic infections. This usually re-
quires the serum IgG level to be maintained above 200 mg/100 ml and to do this a
dose of 0.7 ml/kg of the 16 g/100 ml concentrated gammaglobulin is usually re-
quired. The concentrate spontaneously aggregates forming macromolecular com-
plexes that activate the complement system and cause shock ifgiven intravenously,
hence theneed fordeep im injectionsoftheglobulin.
Cell-MediatedImmunity
From 10 wk of fetal life the thymus, which has descended through the neck with
the parathyroid glands to overlay the great vessels of the heart, turns pluripotential
stem cells into T lymphocytes that will mediate the cellular immune system (21).
These cells live in the paracortical area oflymph nodes and around the general cen-
ters of the spleen, and in the white pulp of the spleen. They compromise 60-65% of
the lymphocytes found in peripheral blood. They recognize antigens via a surface
recognition unit (11) and on so doing divide to form memory cells and effector or
"killer cells" that make physical contact with antigens and release a host of
pharmacologically active agents called "lymphokines." These are responsible for
recruiting, nonspecifically, other cells into the battle and produce the inflammatory
response that eliminates the target oftheir attack (22).
When stem-cell defects cause immunodeficiency, neither the microenvironment of
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the bone marrow nor the thymus can educate lymphocytes resulting in combined
immune-deficiency syndromes. Isolated defects due to thymus abnormalities are
less common. The best-known isolated defect is the DiGeorge syndrome (23) in
which failure of thymus differentiation is associated with parathyroid abnormalities
and disturbances of the great vessels, an obviously "pinpointable" embryonic
disaster, or these structures all arise from the third and fourth pharyngeal pouches
and descend together through the neck (24). Such children commonly have dis-
tinctive facial features and clinically frequently present because of hypocalcemic
fitting. Their chest x-rays show a lack of the normal thymic shadow, and their im-
mune problems lead to serious viral and fungal infections. Partial defectsin theCMI
system are being increasingly recognized.
T cells can be visualized at work by stimulating them to produce a dermal delayed
hypersensitivity response. In the neonatal period this can be achieved by intradermal
challenging with phytohemagglutinin (PHA), a T-cell mitogen that produces a small
(5-10 mm) reaction at 24 hr. In older children positive skin reactions to Candida al-
bicans, mumps, or streptokinase-streptodornase are good indicators ofintact cell-
mediated immunity. Negative reactions to all three, while not proof of a defect, are
enough to rouse suspicions. The further evaluation of T-cell function involves
enumeration of peripheral blood T cells and in vitro stimulation of T cells with
phytohemagglutinin, Candida albicans, and seeing if the T cells in question can take
part in a mixed lymphocyte reaction. Such tests are readily available at all major
centers. For combined immune deficiency bone marrow from a perfectly histocom-
patible donor (usually a sibling) must be transplanted to the patient. Although such
marrow is hard to come by, at least two dozen successful transplants have been
reported (25). Thymic deficiencies require the transplantation of fetal thymic tissue
which has been very successful in a number of cases (26). Defects in postthymic T-
cell function occasionally improve with the administration of transfer factor, a
dialyzable product of healthy human leukocytes. The latter has been particularly
successful in treating chronic mucocutaneous candidiasis (27). T- and/or B-cell de-
fects may be associated with abnormalities in other systems producing many syn-
dromes but the immune defects can all be reduced to the above terms.
Complement
Circulating in serum are 11 inactive complement proteins that can interact in
chain-reaction fashion once the first component (called Clq) is activated by changes
in the heavy chains of IgG or IgM antibodies bound to antigen (28). The cascade
that follows, wherein one activated component activates the next step in the
reaction, results in a general amplification of humoral immune responses and some
specific pharmacological effects. Many of the activated components, apart from
pushing the reactions forward, are pharmacologically active in one or more of four
areas. Some cause vascular smooth-muscle relaxation, others cause an increase in
capillary permeability, while others either attract macrophages or lyse cell
membranes (28). All of these effects greatly aid in the production of an inflamma-
tory response. These powerful molecules are kept in check by a series of serum inac-
tivators of complement. This pathway, activated by antigen-antibody complexes is
called "the classical pathway." Nonimmunological happenings, e.g., endotoxin, can
activate an alternate pathway that bypasses the first three steps of the classical se-
quence (28). Such activation may involve complement in many nonspecific inflam-
matory responses. A deficiency of a complement component that is vital to the se-
quence reaction as a whole, effectively inactivates the system. So far inborn errors of
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complement in man have produced deficiencies in C1, C2, C3, C5, C6, and C7. All
cases have been associated with either repeated infections or the systemic lupus
erythematosus cluster ofdiseases (28).
When infections cannot be attributed to lymphocyte or phagocytic abnormalities,
the complement activity of serum or a major individual component such as C3
should be measured. Complement may be low secondary to utilization by antigen-
antibody complexes in diseases associated with this phenomenon. In these, com-
plement levels usually rise with treatment and complement activity is seldom
reduced to 10% of normal as is common in the inborn errors of the complement
system. Treatment of primary complement failure is limited to fresh plasma infu-
sions and thegeneral caredescribed above.
Phagocytic Cells
Once several of the complement components have bound to an antigen-antibody
complex they promote phagocytosis by macrophages, etc. This so-called opsonic
activity of complement will help in the ingestion of a microorganism, but it is up to
the phagocytic cell to kill the infecting agent. The ability to swallow is not
necessarily related to the ability to kill and it is in this latter area that problems arise
leading to grossly inadequate protection from bacterial infection. Inside phagocytic
cells biochemical reactions involving a hexose-monophosphate shunt and numerous
intracellular enzymes dispatch the organisms (29). Failure ofthehexose-monophos-
phate shunt mechanism results in an early death from infection. The full-blown form
of this defect produces a syndrome known as Chronic Granulomatous Disease of
Childhood (30). In addition to a spleen scan to detect a congenital absence of the
spleen, the easiest way to approach a diagnosis ofdefective phagocytic killing is via
the nitro-blue tetrazolium (NBT) test (31). NBT is a colorlessdye but when added to
macrophages that are utilizing the hexose-monophosphate shunt the dye is reduced
to the purple formozan. This test is availablein many centers and is agood screening
test for chronic granulomatous disease. More sophisticated tests include the
creation of a "skin window" (Rebuck) by abrasion of the skin with subsequent ob-
servation of the cells that pour into the injured area and quantitative bacterial
phagocytic assays (32). There is currently no satisfactory treatment for such
children, but the intensive research into phagocytic metabolism, current in many in-
stitutions, may provide rapid improvements in this area. These children require con-
tinuous antibiotic coverage.
The neonate in London in 1750 had a 70% chance ofsurviving his first year, much
better odds than those available- to the undiagnosed child with a host-defense im-
pairment in America in 1974. However, with a wider appreciation and understanding
of the possible defects that can occur and the manner in which they can be defined,
such afflicted children will have an increasingly greater chance of being restored to
health, allowing them to defect from the ranks ofchildren who present with frequent
and severe infections.
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